Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 28974506

Five-year results of brentuximab vedotin in patients with relapsed or refractory systemic anaplastic large cell lymphoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2017 Dec 21
First author
Pro B

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2017 Dec 21;130(25):2691-2692. doi: 10.1182/blood-2017-10-811083.
    note
    Source null
    related pmid
    29269528
    relationship
    Comment in
  2. citation
    Blood. 2018 Jul 26;132(4):458-459. doi: 10.1182/blood-2018-05-853192.
    note
    Source null
    related pmid
    30049735
    relationship
    Erratum in

Authors and identifiers

  1. name
    Pro B
    type
    Author
  2. name
    Advani R
    type
    Author
  3. name
    Brice P
    type
    Author
  4. name
    Bartlett NL
    type
    Author
  5. name
    Rosenblatt JD
    type
    Author
  6. name
    Illidge T
    type
    Author
  7. name
    Matous J
    type
    Author
  8. name
    Ramchandren R
    type
    Author
  9. name
    Fanale M
    type
    Author
  10. name
    Connors JM
    type
    Author
  11. name
    Fenton K
    type
    Author
  12. name
    Huebner D
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Pro B
    type
    Author
  2. name
    Advani R
    type
    Author
  3. name
    Brice P
    type
    Author
  4. name
    Bartlett NL
    type
    Author
  5. name
    Rosenblatt JD
    type
    Author
  6. name
    Illidge T
    type
    Author
  7. name
    Matous J
    type
    Author
  8. name
    Ramchandren R
    type
    Author
  9. name
    Fanale M
    type
    Author
  10. name
    Connors JM
    type
    Author
  11. name
    Fenton K
    type
    Author
  12. name
    Huebner D
    type
    Author
bibliography ids
  1. nci-bib-dd0de6f96bc636b3d7233fb2
book metadata
content sha256
544f91ca69e2fbb9ce72308e46bd5290f9518052c88134bcf997bc796f5a9c2c
document type
citation
dois
  1. 10.1182/blood-2017-05-780049
electronic publication date
display
2017 Oct 3
precision
day
year
2017
evidence scope
bibliographic_metadata_only
id
pubmed:28974506
immutable id
pubmed:28974506@544f91ca69e2fbb9ce72308e46bd5290f9518052c88134bcf997bc796f5a9c2c
journal
abbreviation
Blood
issn electronic
1528-0020
issn print
0006-4971
issue
25
name
Blood
nlm unique id
7603509
pages
2709-2717
volume
130
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2017 Dec 21;130(25):2691-2692. doi: 10.1182/blood-2017-10-811083.
    note
    Source null
    related pmid
    29269528
    relationship
    Comment in
  2. citation
    Blood. 2018 Jul 26;132(4):458-459. doi: 10.1182/blood-2018-05-853192.
    note
    Source null
    related pmid
    30049735
    relationship
    Erratum in
outcomes validated
false
pmid
28974506
provenance
batch id
fb25b16edcb1373b70c1
provider
NCBI PubMed ESummary
record sha256
cef90dab3448fd964f597b255154c563ec3c1ac3face1ba0e37e42ac82a3261e
response sha256
182c99bf1974b58308315b66aa28d31c61e8fc31cf3de4cadb0340a4f6734c52
retrieved at
2026-09-09T23:47:28.490065+00:00
publication date
display
2017 Dec 21
precision
day
year
2017
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Multicenter Study
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/28974506/
title
Five-year results of brentuximab vedotin in patients with relapsed or refractory systemic anaplastic large cell lymphoma.

Preserved source evidence · Independent clinical review pending · Not medical advice